Sustained release of prindopril erbumine from its chitosan-coated magnetic nanoparticles for biomedical applications

International Journal of Molecular Sciences

Volumn 14, Issue 12, 2013, Pages 23639-23653

  Dorniani, Dena ^a   Hussein, Mohd Zobir Bin ^a   Kura, Aminu Umar ^a   Fakurazi, Sharida ^a   Shaari, Abdul Halim ^a   Ahmad, Zalinah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Chitosan; Drug delivery; Prindopril erbumine; Superparamagnetic nanoparticles

Indexed keywords

CHITOSAN; IRON OXIDE; MAGNETIC NANOPARTICLE; NANOCOMPOSITE; PERINDOPRIL TERT BUTYLAMINE; DRUG CARRIER; MAGNETITE; MAGNETITE NANOPARTICLE; PERINDOPRIL;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MOUSE; NONHUMAN; SUSTAINED DRUG RELEASE; THERMAL ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION; 3T3 CELL LINE; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; KINETICS; MAGNETISM; PARTICLE SIZE; PH; THERMOGRAVIMETRY; TOXICITY; ULTRASTRUCTURE; X RAY DIFFRACTION;

3T3 CELLS; ANIMALS; CELL SURVIVAL; CHITOSAN; DRUG CARRIERS; FERROSOFERRIC OXIDE; HYDROGEN-ION CONCENTRATION; KINETICS; MAGNETICS; MAGNETITE NANOPARTICLES; MICE; PARTICLE SIZE; PERINDOPRIL; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 84889563110     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141223639     Document Type: Article

References (45)

1. Perrone Donnorso, M.; Miele, E.; de Angelis, F.; la Rocca, R.; Limongi, T.; Cella Zanacchi, F.; Marras, S.; Brescia, R.; di Fabrizio, E. Nanoporous silicon nanoparticles for drug delivery applications. Microelectron. Eng. 2012, 98, 626-629.
2. Petros, R.A.; DeSimone, J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discovery 2010, 9, 615-627.
3. Li, L.; Mak, K.Y.; Shi, J.; Leung, C.H.; Wong, C.M.; Leung, C.W.; Mak, C.S.K.; Chan, K.Y.; Chan, N.M.M.; Wu, E.X. Sterilization on dextran-coated iron oxide nanoparticles: Effects of autoclaving, filtration, UV irradiation, and ethanol treatment. Microelectron. Eng. 2013, 111, 310-313.
4. Lind, K.; Kresse, M.; Debus, N.P.; Müller, R.H. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: Comparison of physicochemical properties and the in vivo behaviour. J. Drug Target. 2002, 10, 221-230.
5. Qu, J.-B.; Shao, H.-H.; Jing, G.-L.; Huang, F. PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: Preparation, characterization and cytotoxicity studies. Colloids Surf. B 2013, 102, 37-44.
6. Kong, X.; Li, X.; Wang, X.; Liu, T.; Gu, Y.; Guo, G.; Luo, F.; Zhao, X.; Wei, Y.; Qian, Z. Synthesis and characterization of a novel MPEG-chitosan diblock copolymer and self-assembly of nanoparticles. Carbohydr. Polym. 2010, 79, 170-175.
7. Schweiger, C.; Pietzonka, C.; Heverhagen, J.; Kissel, T. Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: Synthesis, stability, cytotoxicity and MR imaging. Int. J. Pharm. 2011, 408, 130-137.
8. Garlotta, D. A literature review of poly(lactic acid). J. Polym. Environ. 2001, 9, 63-84.
9. Neu, M.; Fischer, D.; Kissel, T. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J. Gene Med. 2005, 7, 992-1009.
10. Pardoe, H.; Chua-Anusorn, W.; St Pierre, T.G.; Dobson, J. Structural and magnetic properties of nanoscale iron oxide particles synthesized in the presence of dextran or polyvinyl alcohol. J. Magn. Magn. Mater. 2001, 225, 41-46.
11. Lehr, C.-M.; Bouwstra, J.A.; Schacht, E.H.; Junginger, H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 1992, 78, 43-48.
12. Jain, T.K.; Morales, M.A.; Sahoo, S.K.; Leslie-Pelecky, D.L.; Labhasetwar, V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharm. 2005, 2, 194-205.
13. Tsai, Z.-T.; Wang, J.-F.; Kuo, H.-Y.; Shen, C.-R.; Wang, J.-J.; Yen, T.-C. In situ preparation of high relaxivity iron oxide nanoparticles by coating with chitosan: A potential MRI contrast agent useful for cell tracking. J. Magn. Magn. Mater. 2010, 322, 208-213.
14. Qu, J.; Liu, G.; Wang, Y.; Hong, R. Preparation of Fe3O4-chitosan nanoparticles used for hyperthermia. Adv. Powder Technol. 2010, 21, 461-467.
15. Ravi Kumar, M.N.V. A review of chitin and chitosan applications. React. Funct. Polym. 2000, 46, 1-27.
16. Agnihotri, S.A.; Mallikarjuna, N.N.; Aminabhavi, T.M. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J. Control. Release 2004, 100, 5-28.
17. Burt, V.L.; Cutler, J.A.; Higgins, M.; Horan, M.J.; Labarthe, D.; Whelton, P.; Brown, C.; Roccella, E.J. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population data from the health examination surveys, 1960 to 1991. Hypertension 1995, 26, 60-69.
18. Chobanian, A.V.; Bakris, G.L.; Black, H.R.; Cushman, W.C.; Green, L.A.; Izzo, J.L.; Jones, D.W.; Materson, B.J.; Oparil, S.; Wright, J.T. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42, 1206-1252.
19. Clark, L.T. Safety profile of perindopril. Am. J. Cardiol. 2001, 88, 36-40.
20. Wong, J.; Patel, R.A.; Kowey, P.R. The clinical use of angiotensin-converting enzyme inhibitors. Prog. Cardiovasc. Dis. 2004, 47, 116-130.
21. Bertrand, M.E. Provision of cardiovascular protection by ACE inhibitors: A review of recent trials. Curr. Med. Res. Opin. 2004, 20, 1559-1569.
22. Laurent, S.P. Evidence for benefits of perindopril in hypertension and its complications. Am. J. hypertens. 2005, 18, 155S-162S.
23. Remková, A.; Kratochvil'ova, H. Impact of the therapy by renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension. J. Hum. Hypertens. 2008, 22, 338-345.
24. Pascard, C.; Guilhem, J.; Vincent, M.; Remond, G.; Portevin, B.; Laubie, M. Configuration and preferential solid-state conformations of perindoprilat (S-9780). Comparison with the crystal structures of other ACE inhibitors and conclusions related to structure-activity relationships. J. Med. Chem. 1991, 34, 663-669.
25. Al Ali, S.H.H.; Al-Qubaisi, M.; Hussein, M.Z.; Ismail, M.; Zainal, Z.; Hakim, M.N. Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. Int. J. Nanomed. 2012, 7, 2129-2141.
26. Zhang, B.; Wang, D.-F.; Li, H.-Y.; Xu, Y.; Zhang, L. Preparation and properties of chitosan-soybean trypsin inhibitor blend film with anti-Aspergillus flavus activity. Ind. Crop. Prod. 2009, 29, 541-548.
27. Fan, M.; Hu, Q.; Shen, K. Preparation and structure of chitosan soluble in wide pH range. Carbohydr. Polym. 2009, 78, 66-71.
28. Zhao, Y.; Qiu, Z.; Huang, J. Preparation and analysis of Fe3O4 magnetic nanoparticles used as targeted-drug carriers. Chin. J. Chem. Eng. 2008, 16, 451-455.
29. Kuo, C.-H.; Liu, Y.-C.; Chang, C.-M.J.; Chen, J.-H.; Chang, C.; Shieh, C.-J. Optimum conditions for lipase immobilization on chitosan-coated Fe3O4 nanoparticles. Carbohydr. Polym. 2012, 87, 2538-2545.
30. Kipkemboi, P.K.; Kiprono, P.C.; Sanga, J.J. Vibrational spectra of t-butyl alcohol, t-butylamine and t-butyl alcohol + t-butylamine binary liquid mixtures. Bull. Chem. Soc. Ethiop. 2003, 17, 211-218.
31. Smith, B.C. Infrared Spectral Interpretation: A Systematic Approach; CRC Press: Boca Raton, FL, USA, 1999.
32. Tronto, J.; dos Reis, M.J.; Silvério, F.; Balbo, V.R.; Marchetti, J.M.; Valim, J.O.B. In vitro release of citrate anions intercalated in magnesium aluminium layered double hydroxides. J. Phys. Chem. Solids 2004, 65, 475-480.
33. Yasin, Y.; Ismail, N.M.; Hussein, M.Z.; Aminudin, N. Synthesis and characterization of lawsone-intercalated ZnAl layered double hydroxides. J. Biomed. Nanotechnol. 2011, 7, 486-488.
34. Ge, Y.; Zhang, Y.; Xia, J.; Ma, M.; He, S.; Nie, F.; Gu, N. Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro. Colloids Surf. B 2009, 73, 294-301.
35. Li, G.-Y.; Jiang, Y.-R.; Huang, K.-L.; Ding, P.; Chen, J. Preparation and properties of magnetic Fe3O4-chitosan nanoparticles. J. Alloy. Compd. 2008, 466, 451-456.
36. Macêdo, R.O.; do Nascimento, T.G.; Aragǎo, C.F.S.; Gomes, A.P.B. Application of thermal analysis in the characterization of anti-hypertensive drugs. J. Therm. Anal. Calorim. 2000, 59, 657-661.
37. Zhang, H.; Zou, K.; Sun, H.; Duan, X. A magnetic organic-inorganic composite: Synthesis and characterization of magnetic 5-aminosalicylic acid intercalated layered double hydroxides. J. Solid State Chem. 2005, 178, 3485-3493.
38. Ambrogi, V.; Fardella, G.; Grandolini, G.; Perioli, L.; Tiralti, M.C. Intercalation compounds of hydrotalcite-like anionic clays with anti-inflammatory agents, II: Uptake of diclofenac for a controlled release formulation. AAPS PharmSciTech 2002, 3, 77-82.
39. Saifullah, B.; Hussein, M.Z.; Hussein-Al-Ali, S.H.; Fakurazi, S. Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite. Chem. Cent. J. 2013, 7, 72.
40. Kura, A.U.; Al Ali, S.H.H.; Hussein, M.Z.; Fakurazi, S.; Arulselvan, P. Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent. Int. J. Nanomed. 2013, 8, 1103-1110.
41. Ho, Y.-S.; Ofomaja, A.E. Pseudo-second-order model for lead ion sorption from aqueous solutions onto palm kernel fiber. J. Hazard. Mater. 2006, 129, 137-142.
42. Dong, L.; Yan, L.; Hou, W.-G.; Liu, S.-J. Synthesis and release behavior of composites of camptothecin and layered double hydroxide. J. Solid State Chem. 2010, 183, 1811-1816.
43. Ankamwar, B.; Lai, T.C.; Huang, J.H.; Liu, R.S.; Hsiao, M.; Chen, C.H.; Hwu, Y.K. Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology 2010, 21, 075102.
44. Lee, H.; Shao, H.; Huang, Y.; Kwak, B. Synthesis of MRI contrast agent by coating superparamagnetic iron oxide with chitosan. Magn. IEEE Trans. 2005, 41, 4102-4104.
45. Dorniani, D.; Hussein, M.Z.B.; Kura, A.U.; Fakurazi, S.; Shaari, A.H.; Ahmad, Z. Preparation of Fe3O4 magnetic nanoparticles coated with gallic acid for drug delivery. Int. J. Nanomed. 2012, 7, 5745-5756.